LA
BSX icon

Legacy Advisors’s Boston Scientific BSX Stock Holding History

Legacy Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$394K Buy
3,905
+446
+13% +$44.9K 0.04% 293
2024
Q4 		$309K Buy
3,459
+386
+13% +$34K 0.03% 309
2024
Q3 		$258K Buy
3,073
+253
+9% +$19.9K 0.03% 319
2024
Q2 		$217K Buy
+2,820
New +$206K 0.03% 304

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legacy Advisors's BSX Position: Q1 2025 in Review

Legacy Advisors increased its Boston Scientific (BSX) stake by 13% in Q1 2025, buying an estimated $44.9K and bringing the position to 3,905 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #293.

Legacy Advisors first reported a position in BSX in Q2 2024 and has held it in 4 quarters since. 1,650 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Legacy Advisors held 3,905 shares of Boston Scientific worth $394K as of Q1 2025.
  • Legacy Advisors bought 446 Boston Scientific shares in Q1 2025, an estimated $44.9K.
  • Boston Scientific made up 0.04% of Legacy Advisors's portfolio in Q1 2025, its #293 holding.
  • Legacy Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 4 quarters since.
  • 1,650 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.